Status:
COMPLETED
The Association of G9a Protein and the Outcome of Patients With Cervical Cancer
Lead Sponsor:
Far Eastern Memorial Hospital
Conditions:
Cervical Cancer
Eligibility:
FEMALE
20-99 years
Brief Summary
G9a protein was approved to be highly associated with recurrence of breast cancer, gastric cancer, hepatocellular cancer, prostate cancer and lung cancer. Therefore, the aim of this study was to clari...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- cases with cervical cancer
Exclusion
Key Trial Info
Start Date :
February 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT01505751
Start Date
February 1 2012
End Date
February 1 2015
Last Update
September 7 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital
Banqiao District, New Taipei, Taiwan, 22050